9-(2,3-dihydroxypropyl)adenine, (s)-isomer has been researched along with Leukemia L 1210 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balzarini, J; De Clercq, E; Krowicki, K; Lown, JW | 1 |
| Balzarini, J; Borchardt, RT; De Clercq, E; Robins, MJ; Wnuk, SF; Yuan, CS | 1 |
2 other study(ies) available for 9-(2,3-dihydroxypropyl)adenine, (s)-isomer and Leukemia L 1210
| Article | Year |
|---|---|
Structure-activity relationship of novel oligopeptide antiviral and antitumor agents related to netropsin and distamycin.
Topics: Animals; Antineoplastic Agents; Antiviral Agents; Cell Line; Distamycins; Drug Evaluation, Preclinical; Guanidines; Humans; Indicators and Reagents; Leukemia L1210; Mice; Netropsin; Oligopeptides; Pyrroles; Structure-Activity Relationship; Vaccinia virus | 1986 |
Anticancer and antiviral effects and inactivation of S-adenosyl-L-homocysteine hydrolase with 5'-carboxaldehydes and oximes synthesized from adenosine and sugar-modified analogues.
Topics: Adenosine; Adenosylhomocysteinase; Aldehydes; Animals; Antineoplastic Agents; Antiviral Agents; Carbohydrates; Cell Line; Cytomegalovirus; Dogs; Enzyme Inhibitors; Humans; Hydrolases; Leukemia L1210; Mammary Neoplasms, Experimental; Oximes; Tumor Cells, Cultured; Vaccinia virus | 1997 |